tradingkey.logo

Prophase Labs Inc

PRPH
0.615USD
-0.072-10.48%
收盤 12/24, 13:00美東報價延遲15分鐘
2.55M總市值
虧損本益比TTM

Prophase Labs Inc

0.615
-0.072-10.48%

關於 Prophase Labs Inc 公司

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Prophase Labs Inc簡介

公司代碼PRPH
公司名稱Prophase Labs Inc
上市日期Jan 16, 1984
CEOKarkus (Ted William)
員工數量96
證券類型Ordinary Share
年結日Jan 16
公司地址711 Stewart Ave, Suite 200
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編11530
電話12153450919
網址https://www.prophaselabs.com/
公司代碼PRPH
上市日期Jan 16, 1984
CEOKarkus (Ted William)

Prophase Labs Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.22M
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
103.84K
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.22M
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
103.84K
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Karkus (Ted William)
5.57%
Sykon Capital LLC
1.12%
The Vanguard Group, Inc.
0.92%
Susquehanna International Group, LLP
0.69%
Geode Capital Management, L.L.C.
0.53%
其他
91.17%
持股股東
持股股東
佔比
Karkus (Ted William)
5.57%
Sykon Capital LLC
1.12%
The Vanguard Group, Inc.
0.92%
Susquehanna International Group, LLP
0.69%
Geode Capital Management, L.L.C.
0.53%
其他
91.17%
股東類型
持股股東
佔比
Individual Investor
5.75%
Investment Advisor
4.32%
Investment Advisor/Hedge Fund
0.70%
Hedge Fund
0.10%
Research Firm
0.08%
Venture Capital
0.05%
其他
88.99%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
86
3.04M
7.33%
-2.51M
2025Q2
91
7.80M
18.77%
+525.30K
2025Q1
95
8.38M
29.57%
+1.62M
2024Q4
97
6.02M
20.15%
-197.61K
2024Q3
101
5.16M
20.53%
-1.27M
2024Q2
102
5.11M
20.47%
-1.25M
2024Q1
100
5.62M
31.27%
-1.27M
2023Q4
102
5.60M
32.69%
-985.39K
2023Q3
105
5.94M
34.65%
-718.97K
2023Q2
102
6.16M
36.72%
-636.57K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Karkus (Ted William)
3.22M
7.74%
--
--
Apr 29, 2025
Sykon Capital LLC
644.79K
1.55%
+644.79K
--
Jun 30, 2025
The Vanguard Group, Inc.
408.27K
0.98%
--
--
Jun 30, 2025
Susquehanna International Group, LLP
102.02K
0.25%
+28.00K
+37.84%
Jun 30, 2025
Geode Capital Management, L.L.C.
259.06K
0.62%
+31.37K
+13.78%
Jun 30, 2025
Gleckel (Louis)
103.84K
0.25%
--
--
Apr 29, 2025
Chapin Davis Asset Management
80.00K
0.19%
--
--
Jun 30, 2025
Swisspartners Investment Network AG
50.00K
0.12%
+50.00K
--
Jun 30, 2024
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Dimensional US Core Equity 1 ETF
0%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
佔比0%
Avantis US Equity ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
Dec 12, 2025
Merger
10→1
公告日期
類型
比率
Dec 12, 2025
Merger
10→1

常見問題

Prophase Labs Inc的前五大股東是誰?

Prophase Labs Inc的前五大股東如下:
Karkus (Ted William)
持有股份:3.22M
佔總股份比例:7.74%。
Sykon Capital LLC
持有股份:644.79K
佔總股份比例:1.55%。
The Vanguard Group, Inc.
持有股份:408.27K
佔總股份比例:0.98%。
Susquehanna International Group, LLP
持有股份:102.02K
佔總股份比例:0.25%。
Geode Capital Management, L.L.C.
持有股份:259.06K
佔總股份比例:0.62%。

Prophase Labs Inc的前三大股東類型是什麼?

Prophase Labs Inc 的前三大股東類型分別是:
Karkus (Ted William)
Sykon Capital LLC
The Vanguard Group, Inc.

有多少機構持有Prophase Labs Inc(PRPH)的股份?

截至2025Q3,共有86家機構持有Prophase Labs Inc的股份,合計持有的股份價值約為3.04M,占公司總股份的7.33% 。與2025Q2相比,機構持股有所增加,增幅為-11.44%。

哪個業務部門對Prophase Labs Inc的收入貢獻最大?

在--,--業務部門對Prophase Labs Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI